Avicanna Stock Fundamentals
| AVCN Stock | CAD 0.27 0.01 3.85% |
Avicanna fundamentals help investors to digest information that contributes to Avicanna's financial success or failures. It also enables traders to predict the movement of Avicanna Stock. The fundamental analysis module provides a way to measure Avicanna's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Avicanna stock.
Avicanna |
Avicanna Company Current Valuation Analysis
Avicanna's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Avicanna Current Valuation | 29.02 M |
Most of Avicanna's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Avicanna is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Avicanna has a Current Valuation of 29.02 M. This is 99.8% lower than that of the Pharmaceuticals sector and 99.61% lower than that of the Health Care industry. The current valuation for all Canada stocks is 99.83% higher than that of the company.
Avicanna Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Avicanna's current stock value. Our valuation model uses many indicators to compare Avicanna value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Avicanna competition to find correlations between indicators driving Avicanna's intrinsic value. More Info.Avicanna is rated fourth in return on equity category among its peers. It also is rated fourth in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Avicanna by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Avicanna's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Avicanna Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Avicanna's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Avicanna could also be used in its relative valuation, which is a method of valuing Avicanna by comparing valuation metrics of similar companies.Avicanna is currently under evaluation in current valuation category among its peers.
Avicanna Fundamentals
| Return On Equity | -1.12 | |||
| Return On Asset | -0.21 | |||
| Profit Margin | (0.30) % | |||
| Operating Margin | (0.29) % | |||
| Current Valuation | 29.02 M | |||
| Shares Outstanding | 109.57 M | |||
| Shares Owned By Insiders | 23.21 % | |||
| Number Of Shares Shorted | 303.15 K | |||
| Price To Book | 821.67 X | |||
| Price To Sales | 1.12 X | |||
| Revenue | 16.79 M | |||
| Gross Profit | 1.12 M | |||
| EBITDA | (6.9 M) | |||
| Net Income | (7.89 M) | |||
| Cash And Equivalents | 12.98 M | |||
| Cash Per Share | 0.66 X | |||
| Total Debt | 1.8 M | |||
| Debt To Equity | 6.30 % | |||
| Current Ratio | 4.31 X | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (1.4 M) | |||
| Short Ratio | 1.26 X | |||
| Earnings Per Share | (0.10) X | |||
| Target Price | 0.7 | |||
| Number Of Employees | 87 | |||
| Beta | 1.43 | |||
| Market Capitalization | 27.94 M | |||
| Total Asset | 21.97 M | |||
| Retained Earnings | (98.71 M) | |||
| Working Capital | (3.51 M) | |||
| Net Asset | 21.97 M |
About Avicanna Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Avicanna's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Avicanna using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Avicanna based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Avicanna Inc. focuses on the research and development, cultivation, manufacture, and commercialization of plant-derived cannabinoid-based products and extracts in North America, Latin America, Europe, and Asia. The company was founded in 2016 and is headquartered in Toronto, Canada. AVICANNA INC operates under Drug Manufacturers - Specialty Generic classification in Canada and is traded on Toronto Stock Exchange. It employs 77 people.
Other Information on Investing in Avicanna Stock
Avicanna financial ratios help investors to determine whether Avicanna Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Avicanna with respect to the benefits of owning Avicanna security.